Auto Amazon Links: No products found. Blocked by captcha.
A recent investigation by File on 4 has revealed that a knee-replacement implant used in numerous operations in the UK had a concerning failure rate long before it was eventually withdrawn. Patients who received the NexGen knee implant shared their stories of being left immobile or reliant on painkillers due to the implant slipping out of place. Following the discovery of a problem with one particular component, hundreds of individuals had to undergo a second corrective operation.
Debbie Booker, a patient from Southampton, underwent knee replacement surgery in 2016, only to experience severe pain a year later while on holiday. Her initial success with the knee implant turned into a nightmare as it started slipping and causing significant damage to her bone. Debbie became dependent on prescription painkillers, leading to long-lasting health issues that impacted her mobility and overall well-being.
Another patient, who chose to remain anonymous, had a similar experience with the knee implant slipping and deteriorating her shin bone, leaving her in excruciating pain and severely immobile. These cases shed light on concerns raised by knee specialists regarding the implant’s design and the company’s delayed response to the identified issues. Prof Eric Masterson’s career was impacted by the failure rate of the implant, leading to questions about his professional competence.
The National Joint Registry flagged concerns about the NexGen implant in 2014, with further issues raised in Ireland two years later. Despite these red flags, Zimmer Biomet, the manufacturer, failed to take immediate action, causing further harm to patients who had received the faulty implants. As more patients faced the need for corrective surgery, the financial burden associated with these revisions soared, leaving many individuals with long-term health problems and substantial costs.
In response to the growing concerns and failure rates, Zimmer Biomet recalled all unused implants and initiated a review process for the 10,000 patients who had received the problematic implants. The company emphasized its commitment to patient safety and quality while acknowledging the need for transparency and compliance with regulatory requirements. As the NHS reviews the case involving Zimmer Biomet NexGen knee implants, patients continue to grapple with the aftermath of a failed product that has led to significant health complications and financial burdens
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found. Blocked by captcha.